Is Ovarian Stimulation Safe for IVF in the U.S., Mexico, and Japan? Key Facts to Know Before Trying to Conceive

As more people begin planning their families earlier, IVF in the U.S., Mexico, and Japan and egg freezing in the U.S., Mexico, and Japan have become increasingly popular options. However, before entering an assisted reproduction cycle, many people worry about ovarian stimulation: Will the injections deplete my eggs early? Will they affect ovarian function?

What Is Ovarian Stimulation?

Each month, a group of antral follicles begins to grow in the ovaries. Under natural conditions, only one dominant follicle usually matures and ovulates, while the remaining follicles naturally regress.

Ovarian stimulation does not use up future eggs ahead of time. Instead, medication helps follicles that would normally regress during the same menstrual cycle continue developing, allowing more mature eggs to be retrieved for future use.

In other words, ovarian stimulation utilizes follicles that are already recruited during the current cycle and does not reduce ovarian reserve for future years.

How Is the Ovarian Stimulation Process Performed?

Before starting ovarian stimulation, doctors typically evaluate ovarian function by assessing factors such as age, Anti-Müllerian Hormone (AMH), Antral Follicle Count (AFC), hormone levels, and medical history.

Once the stimulation cycle begins, patients use fertility medications according to an individualized protocol while undergoing regular ultrasound examinations and hormone monitoring. Follicular development is closely observed, and medication dosages are adjusted based on the ovarian response. When most follicles reach maturity, egg retrieval is scheduled to prepare for egg freezing or in vitro fertilization.

Is Ovarian Stimulation Safe?

When performed under proper medical supervision, ovarian stimulation is generally considered safe.

With increasingly individualized stimulation protocols, physicians adjust treatment according to each patient's age, ovarian reserve, and previous treatment response to minimize the risk of ovarian hyperstimulation. Some patients may experience bloating or mild abdominal discomfort during treatment, but these symptoms usually resolve after the cycle is completed.

For patients with a high ovarian reserve or those who are more likely to develop ovarian hyperstimulation, physicians often modify treatment plans in advance and use more precise medication management to reduce potential risks.

How Can Modern Assisted Reproductive Technology Help?

After mature eggs are retrieved, modern assisted reproductive technology offers much more than fertilization alone.

Today, embryos are typically cultured to the blastocyst stage before undergoing IVF-PGT for embryonic genetic testing. Embryonic genetic testing helps identify embryos with better developmental potential, improves overall pregnancy efficiency, reduces the risk of miscarriage caused by chromosomal abnormalities, and has made IVF-PGT an increasingly important part of clinical reproductive medicine.

The IVF USA team founded by Dr. Nathan Zhang has provided international fertility consultation services for more than ten years, offering U.S. egg freezing, U.S. IVF, and third-party reproductive services. With nearly 20 years of experience in international reproductive medicine, IVF USA recognized the growing diversity and personalization of fertility needs early on and established its presence in the Mexican market, becoming the Chinese representative of Power Fertility Center (POWER IVF) in Mexico. Today, Dr. Nathan Zhang's services have expanded beyond the United States to include IVF and egg freezing in Mexico, Japan, and Thailand, as well as Taiwan and Hong Kong. Following the professional insights shared by IVF USA and Dr. Nathan Zhang can help you better understand IVF in the U.S., Mexico, and Japan, egg freezing in the U.S., Mexico, and Japan, and the latest developments in assisted reproductive technology, allowing you to create a more scientific and long-term fertility plan based on your age, ovarian function, and future family goals.